Palisade Bio (PALI) Interest Coverage Ratio (2010 - 2026)
Palisade Bio's (PALI) quarterly Interest Coverage Ratio came in at 10748.0 in Q1 2026, down 365.28% year-on-year from 4051.55 in Q1 2025, and down 438.42% on a QoQ basis from 1996.2 in Q4 2025.
Palisade Bio (PALI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Interest Coverage Ratio data on file, last reported at 10748.0 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 365.28% year-over-year to 10748.0 in Q1 2026; TTM through Mar 2026 was 2038.0, a 81.21% decrease from a year earlier, with the FY2025 full-year figure at 0.66, down 44.59% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 10748.0, down from 1996.2 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PALI reached as high as 0.07 in Q1 2023 and fell as low as 10748.0 in Q1 2026.
- Historically, Interest Coverage Ratio has averaged 1351.68 across 5 years, with a median of 598.83 in 2024.
- Across the five-year window, Interest Coverage Ratio jumped 99.92% in 2023 and tumbled 398112.77% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1282.67 in 2022, then increased by 18.04% to 1051.33 in 2023, then surged by 35.66% to 676.4 in 2024, then tumbled by 195.12% to 1996.2 in 2025, then plunged by 438.42% to 10748.0 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 10748.0 in Q1 2026, 1996.2 in Q4 2025, and 584.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | -10,748.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,748.00 |
| Dec 31, 2025 | -1,996.20 |
| Sep 30, 2025 | -584.40 |
| Jun 30, 2025 | -1,421.50 |
| Mar 31, 2025 | -2,310.00 |
| Dec 31, 2024 | -676.40 |
| Sep 30, 2024 | -598.83 |
| Jun 30, 2024 | -467.89 |
| Mar 31, 2024 | -282.54 |
| Dec 31, 2023 | -1,051.33 |
| Sep 30, 2023 | -157.42 |
| Jun 30, 2023 | -1,203.00 |
| Mar 31, 2023 | -0.07 |
| Dec 31, 2022 | -1,282.67 |
| Sep 30, 2022 | -53.82 |
| Jun 30, 2022 | -54.12 |
| Mar 31, 2022 | -90.42 |
| Dec 31, 2021 | -1.72 |
| Sep 30, 2021 | -116.00 |
| Jun 30, 2021 | -50.16 |